Clinical Trial Update: Vaginal Progesterone in Twin With Short Cervix [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating vaginal progesterone to prevent preterm birth in twin pregnancies with short cervix has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• Vaginal progesterone (progesterone)

Snippet

Sponsor: Ain Shams University | Conditions: Preterm Birth, Twin Dichorionic Diamniotic Placenta | Phase 3 | Status: COMPLETED